Wikipedia
Merotocin
Merotocin ( INN) (developmental code name FE-202767), also known as carba-1-(4-FBzlGly)dOT, is a potent ( EC < 0.1 nM) and highly selective (>1000-fold over the related vasopressin receptors) peptidic agonist of the oxytocin receptor that was derived from oxytocin. It is under development by Ferring Pharmaceuticals for the treatment of preterm mothers with lactation failure requiring lactation support, and is in phase II clinical trials for this indication.